Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 52111000036112 | ferrous sulfate 325 mg + sodium ascorbate 562.4 mg modified release tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 57571000036113 | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Is a | ferrous sulfate + ascorbic acid | true | Inferred relationship | Some | ||
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has intended active ingredient | ascorbic acid | true | Inferred relationship | Some | 725659167 | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has Australian BoSS | sodium ascorbate | true | Inferred relationship | Some | 725659167 | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has intended active ingredient | ferrous sulfate | true | Inferred relationship | Some | 845107184 | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has Australian BoSS | ferrous sulfate | true | Inferred relationship | Some | 845107184 | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 845107185 | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Is a | ferrous sulfate 325 mg (iron 105 mg) modified release tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ferrogen Iron plus Vitamin C modified release tablet | Is a | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | |
| Ferro-Max C modified release tablet | Is a | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | |
| Ferro-Grad C modified release tablet | Is a | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet, 90 | has MPUU | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | 1 |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet, 30 | has MPUU | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | 1 |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet, 60 | has MPUU | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | 1 |
| ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet, 28 | has MPUU | True | ferrous sulfate 325 mg (iron 105 mg) + sodium ascorbate 562.4 mg modified release tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR